课题基金 / 基金详情

G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES

G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
G 蛋白效应物作为抗肿瘤治疗的靶点
批准号:
3752420
负责人:
E SAUSVILLE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

E SAUSVILLE的其他基金

相似基金

相关文献

中文摘要
翻译
以前的研究表明,乳霜多糖(MP),一种肽衍生物, 具有两亲性的黄蜂毒液,可能会刺激 G蛋白介导的信号传导。我们也知道MP可以破坏 膜结构和改变某些磷脂酶的活性。到 确定膜破裂的结构要求, 改变G蛋白的功能,我们构建了几个类似物, 肽并使用Swiss 3 T3细胞膜对其进行表征。的影响 i)G-蛋白介导的刺激, 磷脂酶-C活性通过GTP γ和蛙皮素和ii)膜 Ca ~(2+)激活的磷脂酶-C和Na,K-ATP酶活性。MP 强烈抑制上述活性,并引起膜 透化作用用Gly取代一个Lys残基, 或C-末端产生肽, 抑制G蛋白刺激的磷脂酶-C,无或轻微膜- 扰动效应。将额外的Lys残基引入MP导致 相反的效果。因此,G蛋白调节和膜破坏 MP的行动似乎不一定是联系在一起的,也可能是分开的。
英文摘要
Previous studies had demonstrated that mastoparan(MP), a peptide derived from wasp venom with amphipathic properties, could potentially stimulate G-protein mediated signalling. It was also known that MP could disrupt membrane structure and alter the activity of certain phospholipases. To determine the structural requirements for disruption of membranes and for alteration of G-protein function, we constructed several analogs of the peptide and characterized them using Swiss 3T3 cell membranes. The effects of these peptides were measured on i) G-protein-mediated stimulation of phospholipase-C activity by GTPgamma and bombesin and ii) the membrane enzyme activities Ca2+-activated phospholipase-C and Na,K-ATPase. MP strongly inhibited all the above activities and caused membrane permeabilization. Substitution of one Lys residue by Gly at either the N- or C- terminal of the MP molecule resulted in peptides which selectively inhibited G-protein-stimulated phospholipase-C with no or slight membrane- perturbing effects. Introduction af additional Lys residues to MP led to the opposite effect. Thus, G-protein modulating and membrane-disrupting actions of MP appear to be not necessarily linked, and may be separated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
  • 批准号:
    3916617
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E SAUSVILLE
  • 依托单位:
IMMUNOTOXIN PROTOCOLS
  • 批准号:
    5201307
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E SAUSVILLE
  • 依托单位:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
  • 批准号:
    3939550
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E SAUSVILLE
  • 依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
  • 批准号:
    3838151
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E SAUSVILLE
  • 依托单位:
海外基金